Synonyms: CB-313 | Lysodren®
mitotane is an approved drug (FDA (1970), EMA (2004))
Compound class:
Synthetic organic
Comment: The molecular mechanism underlying mitotane's clinical effects is complex and poorly understood [1].
|
|
References |
1. Lehmann TP, Wrzesiński T, Jagodziński PP. (2013)
The effect of mitotane on viability, steroidogenesis and gene expression in NCI‑H295R adrenocortical cells. Mol Med Rep, 7 (3): 893-900. [PMID:23254310] |
2. Libè R, Fratticci A, Bertherat J. (2007)
Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer, 14 (1): 13-28. [PMID:17395972] |